Literature DB >> 26377905

The role of early contrast-enhanced chest computed tomography in the aetiological diagnosis of patients presenting with cardiac tamponade or large pericardial effusion.

Stefano Maggiolini1, Caterina C De Carlini2, Luca A Ferri3, Gualtiero I Colombo4, Gaetano Gentile2, Ester Meles2, Beatrice Riva3, Teresa C Casella5, Massimo Imazio6, Antonio Brucato7.   

Abstract

AIMS: The role of chest computed tomography (CT) is not well defined for either diagnosis or management of pericardial disease. The aim of this study was to evaluate the added value of early chest CT in the diagnostic workup for patients presenting with cardiac tamponade or large pericardial effusion of unknown aetiology as the first manifestation of disease. METHODS AND
RESULTS: We performed CT scan on 55 patients with pericardial effusion as defined above, undergoing echo-guided pericardiocentesis. We compared the success rate in making diagnosis and/or staging the underlying disorder of three sequential workups, including, respectively, (i) clinical presentation, inflammatory markers, chest X-ray imaging, (ii) all of the above and pericardial fluid analysis, and (iii) all of the above and chest CT. We were able to make diagnosis in 53 patients (96%): the major cause of effusion was malignancy (38%). Clinical and biochemical data were not able to differentiate non-tumour from tumour patients. CT revealed pathological findings in all patients with malignancy: tumour mass in 15/21 (71%) and pathological lymphadenopathy in the remaining 6 cases. The workup including CT provided a significantly higher diagnostic yield than the other two workups (P < 0.0001), both in the overall population and in the two subgroups of neoplastic (Npl) and non-Npl patients.
CONCLUSION: In all patients with cardiac tamponade or large pericardial effusion, CT was useful either in identifying the underlying disease or in excluding other potential causes of pericardial effusion. We conclude that chest CT is a very useful non-invasive diagnostic tool to identify and stage pericardial diseases. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac tamponade; Computed tomography; Echocardiography; Pericardial effusion; Pericardium

Mesh:

Substances:

Year:  2015        PMID: 26377905     DOI: 10.1093/ehjci/jev225

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

1.  The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion.

Authors:  M Szturmowicz; A Pawlak-Cieślik; A Fijałkowska; J Gątarek; A Skoczylas; M Dybowska; K Błasińska-Przerwa; R Langfort; W Tomkowski
Journal:  Support Care Cancer       Date:  2017-03-03       Impact factor: 3.603

2.  Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality.

Authors:  Kirstine Kobberøe Søgaard; Dóra Körmendiné Farkas; Vera Ehrenstein; Krishnan Bhaskaran; Hans Erik Bøtker; Henrik Toft Sørensen
Journal:  Circulation       Date:  2017-06-29       Impact factor: 29.690

Review 3.  Computed tomography-guided pericardiocentesis: a systematic review concerning contemporary evidence and future perspectives.

Authors:  Eduardo M Vilela; Catarina Ruivo; Claudio E Guerreiro; Marisa P Silva; Ricardo Ladeiras-Lopes; Daniel Caeiro; Gustavo P Morais; João Primo; Pedro Braga; Nuno Ferreira; José Pedro L Nunes; Vasco Gama Ribeiro
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-08-15

Review 4.  Recurrent Pericarditis in Children and Adolescents.

Authors:  Enrico Tombetti; Teresa Giani; Antonio Brucato; Rolando Cimaz
Journal:  Front Pediatr       Date:  2019-10-18       Impact factor: 3.418

5.  Pericardiocentesis With Extended Drainage and Colchicine: New Indication for Malignant Pericardial Effusions?

Authors:  Massimo Imazio
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.